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In order for a dental implant to be restored optimally, it must be placed in an ideal anatomic position. However, this is not always
possible, since physiological wound healing after tooth removal, often results in hard and soft tissue changes which ultimately
compromises ideal implant placement. With the aim of minimising the need for tissue augmentation, several alveolar ridge
preservation(ARP)techniqueshavebeendeveloped.Theseoftenrequiretheuseofgraftingmaterialandthereforeincreasetherisk
of disease transmission. Leukocyte and platelet-rich ﬁbrin (L-PRF) is a newly developed platelet concentrate that is prepared from
the patient’s own blood. Clinical research has indicated that it improves wound healing and stimulates bone formation. We present
a case where L-PRF was successfully used in an ARP procedure to facilitate implant placement in a compromised extraction socket.
1.Introduction
Inorderfora dentalimplant tobe restoredoptimally, it must
be placed in an ideal anatomic position. However, this is
not always possible, since physiological wound healing fol-
lowing either tooth extraction, trauma, or pathology, often
results in a deﬁciency of both hard and soft tissue. Unless
augmentationproceduresarecarriedout,placinganimplant
in these tissue-deﬁcient sites would ultimately compromise
the functional and aesthetic results [1]. Although several
diﬀerent augmentation procedures have been developed,
many of them are associated with a number of disadvantages
such as increased overall cost, the requirement for a second
surgical site, and the use of animal derived products [2].
With the aim of minimizing the need for tissue augmen-
tation, several authors have proposed techniques to preserve
the anatomy of the alveolar ridge after tooth extraction.
T h e s ep r o c e d u r e sh a v ec o l l e c t i v e l yb e e nt e r m e da l v e o l a r
ridge preservation (ARP) or socket preservation [2]. Several
diﬀerent ARP techniques exist, most of which include the
use of a foreign graft materials. Because ARP is a relatively
newprocedure,nolong-termstudiesregardingthetechnique
have been published, and even though several case reports
have been presented, there is no evidence to support the
superiority of one technique over the other.
Recently, Choukroun introduced leukocyte and platelet-
rich ﬁbrin (L-PRF), a second-generation platelet concentrate
that improves healing of the both hard and soft tissues
[3]. We present a case where L-PRF was used in an ARP
procedure to limit ridge resorption after tooth extraction,
in order to maximise the tissue available for ideal implant
placement.
2. Case Presentation
A 43-year-old healthy female presented for the restoration
of her dentition in the upper right jaw. Upon clinical
examination, it was noted that several posterior teeth were
missing from the ﬁrst quadrant and that the only remaining
multirooted tooth (the upper right ﬁrst molar) was severely
periodontally compromised (Figure 1). The radiographic
examination revealed the presence of unextracted roots in
the areas immediately mesial and distal to the remaining
molar (Figure 2). Based on the poor prognosis of the
molar as well as the presence of the unextracted roots,2 Case Reports in Dentistry
Figure 1: Initial presentation.
Figure 2: Radiograph shows hopeless upper molar with retained
roots both mesial and distal to the tooth.
a treatment plan that involved the extraction of the remain-
ing tooth and roots, and subsequently replacing them with
an implant-supported prosthesis, was deemed the best long-
term restorative solution. In order to maximise the amount
of available bone for implant placement, an ARP procedure
was indicated at the time of extraction.
3.InitialVisit
After local anaesthesia had been obtained, the upper right
molar together with the residual tooth roots were extracted
atraumatically by using a 5mm dental luxator (Dentsply
Ltd., Surrey, United Kingdom). The remaining tooth sockets
were curetted and all granulation tissue and socket debris
were removed (Figure 3). At the same time, 30mL of blood
wasdrawnfromtheantecubitalfossaofthepatientintothree
separate blood collecting tubes (Vacuette with Z Serum Clot
Activator, Greiner Bio One International AG, Germany).
These were then immediately centrifuged at 400g for 12
minutes, using a standard tabletop laboratory centrifuge
(PLC-03, Hi-care International, Taiwan). Using this method,
the blood in the tubes separated into three visible layers, that
is, a red blood cell layer (RBC) that occupied the lower most
partofthetube,acell-freelayerthatoccupiedtheuppermost
part of the tube, and an L-PRF layer that was located
between the two (Figure 4). For each tube, the L-PRF layer
was removed, and compressed between saline soaked sterile
gauze to form an “L-PRF membrane” (Figure 5). A total of
three L-PRF membranes were formed and inserted into the
Figure 3: Extraction site immediately after tooth removal.
Figure 4: Formation of L-PRF.
extraction socket site. These were then stabilised using 4–0
braided resorbable sutures (Clinisut, Port Elizabeth, South
Africa)thatweresuturedoverthewoundsite.Oralanalgesics
andachlorhexidine0.2%mouthrinsewasprescribedduring
the healing period, and the patient was followed up two
weeks later.
4.Follow-Up Visit
On the follow-up visit, the extraction site showed signs
of healing with no evidence of residual inﬂammation. The
site was free of infection and the L-PRF membrane was
still clearly visible (Figure 6) .E v e nt h o u g hi tr e m a i n e d
exposed to the oral environment, there were no signs of
membrane disintegration or infection. The patient also
reported minimal pain during the postoperative period.
Because of the positive response to treatment, she was
scheduled for implant placement four weeks later.
5. Implant Placement
Implant placement was carried out 6 weeks after tooth
extraction. A radiograph taken prior to implant placement
conﬁrmed new bone formation in the extraction area
(Figure 7). Upon surgical ﬂap reﬂection, the underlyingCase Reports in Dentistry 3
Figure 5: L-PRF membrane.
Figure 6: Extraction site healing 1 week after tooth removal (note
the visibility of the L-PRF membrane).
Figure 7: Radiograph showing new bone formation.
Figure 8: Flap reﬂection.
Figure 9: Radiograph showing stable peri-implant bone 3 months
after restoration.
alveolar ridge was clearly visible. The ridge had retained
its morphology with no signs of bone resorption or of the
residual socket (Figure 8). At implant insertion, the quality
of the newly formed bone was such that it allowed for the
implant to be inserted at an insertion torque of more than
35Ncm.
6. Prosthetic Management
Eight weeks after implant placement, the implant was re-
stored with a cement retained crown and has since then re-
mained in function without any complications.
At the 3 month follow-up after the restorative treatment
had been completed, radiographic evidence of bone matura-
tion was present at the peri-implant sites (Figure 9).
7. Discussion
The healing of an extraction socket is characterised by both
internal and external changes that ultimately aﬀect the shape
of the alveolar ridge [2]. Studies indicate that during healing,
bone does not regenerate to the level of bone crest or to the
leveloftheneighbouringteeth,andtherefore100%socketﬁll
does not occur. Using an animal model, Araujo and Lindhe
showed that in the ﬁrst 8 weeks following extraction, there is
markedosteoclasticactivity,resultingintheresorptionofthe
facial and lingual bone walls, especially in the crestal region
[4]. They also noted that bone resorption was greater on the
facial wall and that any loss of ridge height was accompanied
by a horizontal losson both facial and lingual walls of the
extraction site.
Alveolar ridge preservation is a relatively new surgical
procedure aimed at retaining maximum bone and soft tissue
after a tooth has been removed [2]. By maintaining the
original ridge morphology, there will be a minimal need
for augmentation procedures thereby allowing the resultant
restoration to be placed in an aesthetically and functionally
ideal position.
During the last decade several diﬀerent ARP techniques
have been developed, most of which include the use of a
graft material that is placed into the extraction socket [2].
This increases the treatment cost as well as increases the risk
of disease transmission. Studies also indicate that in many
cases, the graft material is not totally incorporated into the4 Case Reports in Dentistry
newly formed bone and when compared to sites without
graft material, they show less vital bone formation. In some
cases ARP requires the use of collagen membranes. In these
cases a 25% membrane exposure rate has been reported, and
this directly aﬀects the amount of bone ﬁll that takes place
within the socket [2].
Leukocyte and platelet-rich ﬁbrin (L-PRF) was ﬁrst
described by Choukroun as cited by Dohan et al. 2006 [5].
It is considered a second-generation platelet concentrate and
has been used in various surgical procedures in an attempt
to enhance wound healing. It is prepared from the patient’s
own blood thereby eliminating the possibility of disease
transmission or foreign body reactions.
The preparation technique of L-PRF is simple and
requires no special equipment. Blood is drawn into standard
glass/silica coated blood collection tubes and centrifuged at
a predetermined speed to ensure cell separation. No anti-
coagulants are used during the procedure and natural coag-
ulation can therefore take place. This unique preparation
technique allows L-PRF to trap at least 95% of the platelets
of the collected blood into a ﬁbrin mesh [6]. The ﬁbrin
mesh can then be easily manipulated into a membrane that
allows it to be transferred to any surgical site. Here, high
concentrations of the collected platelets allow for the slow
release of growth factors (GFs) from the platelet granules
[7]. These GFs include vascular endothelium growth factor
(VEGF), platelet-derived growth factor (PDGF), ﬁbroblast
growth factor (FGF), epidermal growth factor (EGF), hepa-
tocytegrowthfactor(HGF),insulin-likegrowthfactor(IGF),
platelet-derived growth factor (PDGF), and transforming-
growth factor-beta (TGF-beta). All of these play a role in
replacing lost tissue, resurfacing of the wound, and restoring
vascular integrity. Compared to other platelet concentrates,
L-PRF releases these factors at a sustained rate over a longer
period, thereby optimising wound healing [8]. Recently,
L-PRF has also been shown to stimulate the growth of
osteoblasts and periodontal ligament cells, both of which are
signiﬁcant for the regeneration of periodontal defects [6, 8–
11].
Because of the in vitro eﬃcacy of L-PRF, several clinical
studies have been carried out to determine its clinical poten-
tial. Currently, L-PRF has been successfully tested in a num-
ber of procedures including maxillofacial surgery, periodon-
tal surgery, and implantology [9]. Mazor et al. successfully
used L-PRF as the only grafting material in a series of sinus
augmentationprocedures[10].WiththistechniqueMazoret
al. were able to demonstrate that L-PRF could stimulate new
bone formation in areas that were previously deﬁcient of the
amount of bone required for implant placement [10]. In a
similar 6-year follow-up study, Simonpeiri et al. were able to
demonstrate that using L-PRF as a sole grafting agent was a
viable long-term option in sinus augmentation procedures
[11].
L-PRFhasalsobeenusedsuccessfullytotreatperiodontal
defects.In vitro studieshaveconﬁrmedthatL-PRFselectively
stimulates the growth of osteoblasts and gingival cells [12].
In a series of clinical trials conducted by Pradeep and
Sharma it was shown that L-PRF could be used as a guided-
tissue-regeneration (GTR) membrane to aﬀect periodontal
regeneration in 3-wall bony defects and degree II furcation
lesions [9, 13]. Del Corso et al. published several case reports
showing the successful use of L-PRF membranes in the
management of both single and multiple gingival recession
defects[14].Theclinicalresultsweremaintainedsuccessfully
for at least one year. Ramakrishnan et al. conﬁrmed this
observation and showed that L-PRF could be used for root
coverage procedures [15].
8. Conclusion
In the above case report, we demonstrated the successful
use of L-PRF in an ARP procedure. The biomaterial acts by
releasing high-concentration growth factors to the wound
site, thereby stimulating healing and new bone formation
[16]. Unlike other ARP procedures, the use of L-PRF is a
simple method that requires minimal cost and reduces the
need for specialised grafting material. Because it is a com-
pletely autologous product, the risk of disease transmission
and graft rejection is negated. Further long-term research
is required to determine whether ARP procedures would
beneﬁt from the use of L-PRF.
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